Skip to main content
To the Editor: The article by Dr. John Chiles and his colleagues (1) in the January 1999 issue about the schizophrenia algorithm developed by the Texas Medication Algorithm Project (TMAP) raises a question. Since clozapine is the final drug choice when other drugs fail, why not use it right off the bat?
I suppose one answer might be that the Food and Drug Administration has recommended it only for drug-resistant patients, but is that recommendation binding? Another reason might be the risk of agranulocytosis, but I have used clozapine with many patients, and in only one case did the drug have to be discontinued because of a drop in the white blood cell count. There are so many advantages. Why delay?
The question also arises about using clozapine in new cases of schizophrenia. It has been shown that young, first-break schizophrenic patients have a better prognosis and less danger of developing chronic illness with early treatment. The cost savings by avoiding hospitalization is another reason it might be advantageous to use clozapine as a first-line treatment. I haven't used clozapine for a newly diagnosed schizophrenic patient, but I'm not sure why. Can the authors comment?

Footnote

Dr. Berman is a psychiatrist in Westport, Connecticut.

References

1.
Chiles JA, Miller AL, Crismon ML, et al: The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm. Psychiatric Services 50:69-74, 1999

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services
Psychiatric Services
Pages: 703
PubMed: 10332912

History

Published online: 1 May 1999
Published in print: May 1999

Authors

Details

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share